Why JHVI?

Johns Hopkins Bloomberg School of Public Health faculty members are leaders in vaccine research and education. Why create a new vaccine entity at JHSPH? The Johns Hopkins Vaccine Initiative will not only promote and encourage current research programs, but will also identify new opportunities in vaccine research and policy development that require a coordinated multidisciplinary approach.

JHSPH is unique in that it has substantial strengths in the areas of vaccine policy, finance, implementation, ethics and vaccine safety, as well as the more traditional areas of preclinical and clinical vaccine research.  By providing a forum for the exchange of ideas, and for project development by individuals with expertise in various disciplines, JHVI will ensure that we continue to remain competitive in our traditional areas of strength, facilitate the development of new research programs, continue to provide exceptional training opportunities on campus and around the world, and enhance the competitiveness of JHSPH faculty for funding in vaccine research and policy-related areas.